Genasys Insider Sale: CFO’s RSU Forfeiture Signals Cash‑Crunch Amid Health‑Tech Pivot
Genasys sees a shift in capital allocation as CFO Cassandra Hernandez‑Monteon forgoes 11,667 RSUs, hinting at tighter liquidity and a pivot toward a new health‑tech partnership that could reshape future earnings.
3 minutes to read









